Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06459583 · ClinicalTrials.gov registry record · NA
Evaluation of Self-Mediated Alternatives for Risk Testing Education and Return of Results
A NA study, sponsored by Banner Health.
- Completed
- Registry status
- NA
- Development phase
- 681
- Enrollment target
NCT06459583: Completed NA study, sponsored by Banner Health.
NCT06459583 is a NA study that has completed, run by Banner Health. The registered enrollment target is 681 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06459583, a NA study, has completed, sponsored by Banner Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 681 participants
- Enrollment target
Study Summary
This randomized non-inferiority study will evaluate self-directed scalable electronic health platform (eHealth) methods for communicating Alzheimer's gene and biomarker results compared to videoconference telehealth disclosure with healthcare providers, as well as characterize the impacts of learning this information on the participant.
Primary Outcome
Anxiety scale
Interventions
- OTHER eHealth Platform
- OTHER Videoconference Telehealth Platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 681 participants |
| Start Date | 2024-10-10 |
| Est. Completion | 2025-11-07 |
| Phase | NA |
What the finished NCT06459583 record still lists
NCT06459583 is an interventional study that assigns participants to a tested intervention. The registered 681 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (51% lower).
The record links to 0 conditions, and to 2 interventions - of which eHealth Platform is the first listed.
NCT06459583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06459583 about?
NCT06459583 is a clinical study titled "Evaluation of Self-Mediated Alternatives for Risk Testing Education and Return of Results". This randomized non-inferiority study will evaluate self-directed scalable electronic health platform (eHealth) methods for communicating Alzheimer's gene and biomarker results compared to videoconference telehealth disclosure with healthcare providers, as well as characterize the impacts of learnin...
What is the current status of trial NCT06459583?
This trial is currently completed. It is a NA study. The enrollment target is 681 participants. The study started on 2024-10-10. Estimated completion is 2025-11-07.
What interventions are being tested in trial NCT06459583?
The interventions under investigation include: eHealth Platform (OTHER), Videoconference Telehealth Platform (OTHER).
Who is sponsoring clinical trial NCT06459583?
This trial is sponsored by Banner Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06459583's enrollment target sits among peer trials
681 151st of 2000 higher than 1,850 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05382559 · 681 participants · Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
- NCT05753748 · 680 participants · NA
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI